Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 Diabetes

NCT05457933 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Type2diabetes
Coronary Artery Disease

Interventions

DRUG: Dapagliflozin
DRUG: Glargine

Sponsor

Medanta, The Medicity, India